December 27, 2017

Immunosenescence in aging: between immune cells depletion and cytokines up-regulation

 2017 Dec 14;15:21. doi: 10.1186/s12948-017-0077-0. eCollection 2017.

Abstract

BACKGROUND:
The immunosenescence is a relatively recent chapter, correlated with the linear extension of the average life began in the nineteenth century and still in progress. The most important feature of immunosenescence is the accumulation in the "immunological space" of memory and effector cells as a result of the stimulation caused by repeated clinical and subclinical infections and by continuous exposure to antigens (inhalant allergens, food, etc.).

December 22, 2017

Feasibility of sustained response through long-term dosing in food allergy immunotherapy

  • Sandra Andorf,
  • Monali Manohar,
  • Tina Dominguez,
  • Whitney Block,
  • Dana Tupa,
  • Rohun A. Kshirsagar,
  • Vanitha Sampath,
  • R. Sharon Chinthrajah and
  • Kari C. NadeauEmail authorView ORCID ID profile
Contributed equally

Abstract
Background
Clinical trials using oral immunotherapy (OIT) for the treatment of food allergies have shown promising results. We previously demonstrated the feasibility of desensitization for up to 5 food allergens simultaneously through OIT. In this observational study, we report the findings of long-term follow-up (LTFU) of the participants treated through a single site OIT phase 1 trial.

December 20, 2017

Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts

Early View
Browse  Early View Articles 
Online Version of Record published before inclusion in an issue 
Summary
Background
Cutaneous warts have a cure rate after therapy of no more than approximately 50%. Recently, we developed and validated a standard assessment tool for warts (Cutaneous WARTS diagnostic tool, CWARTS) based on phenotypical characteristics.

December 18, 2017

Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study

Open Access
Open Peer Review
  • Daniel R. MoralesEmail author,
  • Brian J. Lipworth,
  • Peter T. Donnan,
  • Cathy Jackson and
  • Bruce Guthrie

Abstract
Background
Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population has been poorly quantified.

December 17, 2017

Physiotherapy breathing retraining for asthma: a randomised controlled trial